Insomnia

Insomnia is persistent difficulty falling asleep, staying asleep, or waking too early — despite having enough time and a suitable environment for sleep — that leaves you tired or impaired during the day. It is the most common sleep disorder, and for most people it is highly treatable without lifelong medication.

Almost everyone has a few bad nights. The clinical question is not whether you occasionally sleep poorly but whether the problem is frequent, lasting, and disruptive enough to affect how you function — and, crucially, whether it persists even when you give yourself adequate opportunity to sleep. When those conditions are met, insomnia is recognized as a distinct disorder with its own diagnostic criteria and evidence-based treatments.

What is insomnia?

Insomnia is a 24-hour disorder, not just a nighttime one: it is defined by both a nighttime sleep complaint and a resulting daytime consequence such as fatigue, low mood, irritability, or trouble concentrating. The nighttime complaint can take three forms, and many people have more than one:

• Sleep-onset (initial) insomnia — trouble falling asleep at the start of the night.
• Sleep-maintenance insomnia — waking during the night with difficulty returning to sleep.
• Late or early-morning insomnia — waking earlier than intended and being unable to get back to sleep.

Clinicians classify insomnia mainly by duration:

• Short-term (acute) insomnia lasts less than three months and is often tied to an identifiable stressor — a job change, illness, grief, or travel. It frequently resolves on its own.
• Chronic insomnia disorder occurs at least three nights per week for three months or longer (ICD-10-CM: G47.00 for unspecified insomnia; F51.01 for primary insomnia of nonorganic origin).

Insomnia symptoms are extremely common. Roughly one in three adults reports insomnia symptoms at some point in a given year, and an estimated 10% of adults meet criteria for a chronic insomnia disorder (StatPearls; AASM). It is one of the leading reasons people see a clinician about their health.

What causes insomnia, and who's at risk?

There is rarely one cause. A widely used framework — the "3P model" — describes insomnia as the product of predisposing traits (a tendency toward arousal or worry), precipitating events (a stressor that triggers the first bad nights), and perpetuating factors (habits and beliefs that keep poor sleep going long after the original trigger is gone). That last category is why insomnia so often outlives the event that started it.

Common contributors include:

• Stress and life events. Work pressure, relationship strain, grief, or financial worry are frequent triggers for acute insomnia.
• Mental health conditions. Depression, anxiety, and PTSD are strongly linked to insomnia, and the relationship runs both ways — poor sleep worsens mood, and low mood worsens sleep.
• Medical conditions. Chronic pain, acid reflux, heart and lung disease, an overactive thyroid, neurological disorders, and frequent nighttime urination can all fragment sleep.
• Other sleep disorders. Obstructive sleep apnea, restless legs syndrome, and circadian rhythm disorders (such as shift-work disorder) commonly present as insomnia and must be ruled out.
• Substances and medications. Caffeine, nicotine, alcohol, stimulants, some antidepressants, decongestants, corticosteroids, and certain blood-pressure drugs can disrupt sleep. Alcohol is a particular trap: it may speed sleep onset but fragments sleep later in the night.
• Behaviors and environment. Irregular sleep schedules, long daytime naps, late-evening screen use, and a noisy or bright bedroom perpetuate the problem.

Who is most affected?

Insomnia becomes more common with age. Women are affected more often than men, with risk rising around pregnancy, the postpartum period, and the menopausal transition. Older adults, shift workers, people with chronic medical or psychiatric conditions, and those facing socioeconomic hardship all have higher rates (StatPearls; CDC).

What are the symptoms?

Insomnia spans the whole day. Nighttime features include:

• Lying awake for a long time before falling asleep.
• Waking repeatedly during the night or waking too early.
• Sleep that feels light, broken, or unrefreshing.

Daytime features — the part that makes insomnia a disorder rather than a habit — include:

• Fatigue or low energy.
• Difficulty with attention, concentration, or memory.
• Irritability, anxiety, or depressed mood.
• Daytime sleepiness, reduced motivation, and more errors or near-misses at work or while driving.
• Ongoing worry about sleep itself, which can become a self-perpetuating cycle.

A notable feature of insomnia is the gap between effort and result: people with insomnia often spend ample time in bed yet still feel they cannot sleep, and they may feel "tired but wired" — exhausted but unable to switch off.

How is insomnia diagnosed?

Insomnia is a clinical diagnosis, based on your history rather than a single test. A clinician asks about your sleep pattern, daytime function, medical and psychiatric history, medications, and substance use. Under the criteria shared by the DSM-5 and the International Classification of Sleep Disorders (ICSD-3), chronic insomnia disorder requires all of the following:

• A complaint of difficulty initiating sleep, maintaining sleep, or waking too early.
• The difficulty occurs despite adequate opportunity and circumstances for sleep.
• It produces a daytime consequence (fatigue, mood change, impaired function).
• It occurs at least 3 nights per week.
• It has persisted for at least 3 months (shorter durations are classified as short-term insomnia).
• It is not better explained by another sleep disorder, medical or mental condition, or substance.

Helpful tools and tests:

• Sleep diary. Logging bedtimes, wake times, and night awakenings for one to two weeks is one of the most useful diagnostic aids and helps guide treatment.
• Questionnaires such as the Insomnia Severity Index (ISI) help quantify severity and track progress.
• Actigraphy — a wrist device that estimates sleep-wake patterns over days — can supplement the history in select cases.
• Polysomnography (an overnight sleep study) is not routine for uncomplicated insomnia. It is reserved for when another disorder, such as sleep apnea or periodic limb movements, is suspected (AASM).

Blood tests (for example, thyroid function or iron studies for restless legs) may be ordered when the history points toward a contributing medical cause.

How is insomnia treated?

Treatment follows a stepped approach: behavioral therapy first, medication second and usually short-term or adjunctive.

First line: cognitive behavioral therapy for insomnia (CBT-I)

CBT-I is the recommended first-line treatment for chronic insomnia in adults, endorsed by the American Academy of Sleep Medicine (AASM) and the American College of Physicians (ACP). It is a structured, time-limited program — typically four to eight sessions, delivered in person, by telehealth, or through digital apps — and its benefits tend to last longer than medication because it addresses the habits and thoughts that perpetuate insomnia. Core components include:

• Stimulus control — re-associating the bed with sleep (go to bed only when sleepy; get up if you cannot sleep; use the bed only for sleep and sex).
• Sleep restriction — temporarily limiting time in bed to consolidate and deepen sleep, then expanding it gradually.
• Cognitive restructuring — challenging unhelpful beliefs and worry about sleep.
• Sleep hygiene and relaxation training — consistent schedule, a wind-down routine, a cool dark bedroom, and techniques to lower arousal.

Lifestyle and self-management

Whether or not formal CBT-I is used, the same foundations help: keep a consistent sleep and wake time (including weekends), get morning daylight, exercise regularly but not right before bed, limit caffeine after midday, avoid alcohol as a sleep aid, and reserve the bed for sleep rather than work or screens.

Over-the-counter options

OTC products have a limited, mostly short-term role. Antihistamines such as diphenhydramine and doxylamine cause drowsiness but often produce next-day grogginess and are generally discouraged for older adults because of anticholinergic side effects. Melatonin, a hormone that signals the body's sleep timing, may modestly help with circadian-related problems (such as jet lag or delayed sleep timing) but is not a strong treatment for primary insomnia; quality varies because supplements are not tightly regulated. These products are best discussed with a clinician or pharmacist.

Prescription medication

When medication is needed — usually for those who cannot access or fully respond to CBT-I, or for short-term relief — clinicians choose from several real drug classes, ideally at the lowest effective dose for the shortest necessary time. The 2017 AASM clinical practice guideline issued conditional (weak) recommendations for several specific agents; some newer drugs below were FDA-approved after that guideline and so are not covered by it:

• Dual orexin receptor antagonists (DORAs) — suvorexant (Belsomra), lemborexant (Dayvigo, approved 2019), and daridorexant (Quviviq, approved 2022) block wake-promoting orexin signaling and help with both falling and staying asleep. This newer class is increasingly favored; of these, only suvorexant existed when the 2017 AASM guideline was written.
• Non-benzodiazepine "Z-drugs" — zolpidem (Ambien), eszopiclone (Lunesta), and zaleplon (Sonata) act on GABA receptors and are commonly prescribed for sleep onset and maintenance.
• Melatonin receptor agonist — ramelteon (Rozerem) targets sleep onset and is non-habit-forming.
• Low-dose sedating antidepressant — doxepin (Silenor) is FDA-approved at low doses for sleep maintenance.
• Benzodiazepines (such as temazepam, triazolam) are effective but carry higher risks of dependence, tolerance, and next-day impairment, so they are generally used cautiously and short-term.

All sedative-hypnotics carry potential downsides — daytime drowsiness, dependence, rebound insomnia, and (especially in older adults) falls and confusion. The American Geriatrics Society Beers Criteria advise against routine use of benzodiazepines and Z-drugs in older adults. Choice depends on whether the problem is falling asleep, staying asleep, or both, plus age, other conditions, and medication interactions — a decision to make with a prescriber.

Can insomnia be prevented or managed long-term?

Many cases can be prevented from becoming chronic by treating acute insomnia early and protecting good sleep habits. Practical long-term strategies include:

• A fixed wake-up time, anchored by morning light exposure, to stabilize the body clock.
• A consistent wind-down routine and a bedroom kept cool, dark, and quiet.
• Limiting caffeine, nicotine, and alcohol, and avoiding heavy meals close to bedtime.
• Getting out of bed if you are awake and frustrated rather than "trying harder" to sleep.
• Treating underlying contributors — pain, reflux, depression, anxiety, or sleep apnea.
• Learning CBT-I skills, which remain effective long after the program ends and can be revisited during future rough patches.

When should you see a doctor?

Consider seeing a clinician if sleep problems occur most nights for several weeks, if they impair your daytime functioning, or if self-help and good sleep habits are not enough. Seek prompt or urgent evaluation if you notice any of these red flags:

• Loud snoring, gasping, or witnessed pauses in breathing during sleep — possible sleep apnea.
• Falling asleep unintentionally while driving or working, or other dangerous daytime sleepiness.
• Insomnia alongside depression, hopelessness, or thoughts of self-harm — seek help right away; in the U.S. you can call or text 988 (Suicide & Crisis Lifeline).
• Acting out dreams, leg discomfort relieved by movement, or sudden muscle weakness with emotion, which may signal another sleep or neurological disorder.
• Reliance on alcohol or escalating doses of sleep medication to sleep.
• Insomnia that follows a new medication or persists despite treating an obvious cause.

What's the outlook?

The outlook for insomnia is generally good. Short-term insomnia often resolves once the trigger passes or with brief behavioral measures. For chronic insomnia, CBT-I produces meaningful, durable improvement in most people who complete it, and medications can provide effective relief when used appropriately. Insomnia can run a relapsing course — symptoms may return during stressful periods — but the skills learned in treatment usually shorten and soften those relapses. Because untreated chronic insomnia is associated with higher risks of depression, reduced quality of life, and accidents, treating it is worthwhile beyond the comfort of better nights.

Frequently asked questions

How many hours of sleep do I actually need? Most adults need about seven or more hours per night (CDC), but needs vary. Insomnia is defined by difficulty sleeping plus daytime impairment, not by a specific number — if you feel rested and function well, you are likely getting enough.

Is it bad to take sleeping pills every night? Most prescription sleep medications are intended for short-term or intermittent use because of risks like tolerance, dependence, next-day grogginess, and (in older adults) falls. Some newer agents may be used longer under supervision, but long-term nightly use should always be guided by a clinician, and CBT-I is preferred as the durable solution.

Does melatonin work for insomnia? Melatonin is most useful for problems of sleep *timing* — jet lag or a delayed body clock — rather than classic insomnia. Evidence for chronic insomnia is modest. Because supplements are not tightly regulated, product strength and purity can vary; discuss dosing with a pharmacist or clinician.

Why do I wake at 3 a.m. and can't fall back asleep? Frequent middle-of-the-night waking (sleep-maintenance insomnia) can stem from stress, alcohol, untreated sleep apnea, reflux, pain, depression, or simply spending more time in bed than your body needs. If it happens regularly, a sleep diary and a clinical evaluation can identify the cause.

Can insomnia be cured without medication? Yes — for many people, CBT-I alone resolves chronic insomnia, and its effects tend to outlast those of medication. Behavioral and lifestyle changes are the foundation of long-term improvement, with drugs reserved as a short-term or supplementary tool.

---

*This page is for general education and is not medical advice. Sleep problems can have many causes, including conditions that need specific treatment. Talk with a qualified healthcare professional about diagnosis and any treatment or medication decisions.*